IPILIMUMAB

作品数:44被引量:96H指数:7
导出分析报告
相关领域:医药卫生更多>>
相关作者:谢宗宙林飞燕胡章国周严韩宝惠更多>>
相关机构:海口市人民医院上海市胸科医院东南大学中国科学院更多>>
相关期刊:《细胞与分子免疫学杂志》《华西医学》《Journal of Pharmaceutical Analysis》《临床皮肤科杂志》更多>>
相关基金:国家自然科学基金北京市自然科学基金更多>>
-

检索结果分析

结果分析中...
选择条件:
  • 主题=CHECKPOINTx
条 记 录,以下是1-8
视图:
排序:
Long-Term Persistent Absolute Insulin Secretion Deficiency in Diabetes Induced by Immune Checkpoint Inhibitors
《Open Journal of Endocrine and Metabolic Diseases》2023年第12期227-233,共7页Moctar Bah Clara Bouché Jean-François Gautier 
Immune checkpoint inhibitors are today an immense hope in the management of cancers. However, since their widespread use, many cases of insulin-requiring diabetes appearing suddenly, as fulminant diabetes have been re...
关键词:Immune Checkpoint Inhibitors Nivolumab IPILIMUMAB Fulminant Diabetes Insulin-Requiring Diabetes 
Hypercalcemia and Granulomatous-Like Lesions in a Patient with Melanoma after Treatment with Immunotherapy: Case Report
《Case Reports in Clinical Medicine》2022年第5期188-193,共6页Rebecca A. Takele Alya Z. Aboulhosn Prajwol Pant Paul Laflam 
Checkpoint inhibitors, a subset of immunotherapies, are effective treatment modalities for cancers such as melanoma. However, they are not without possible adverse effects. Drug-induced reactions may present with simi...
关键词:HYPERCALCEMIA Immune Checkpoint Inhibitors Drug-Induced Sarcoido-sis-Like Reaction IPILIMUMAB Nivolumab 
The tumor microenvironment of pancreatic adenocarcinoma and immune checkpoint inhibitor resistance: a perplex relationship
《Cancer Drug Resistance》2020年第4期699-709,共11页Irem Sahin Sevda Turen Pranav Santapuram Ibrahim Halil Sahin 
Pancreatic cancer is one of the most aggressive cancers with a high mortality rate even among patients with early-stage disease.Although recent studies with novel therapeutic approaches have led to modest improvement ...
关键词:Pancreatic adenocarcinoma durvalumab nivolumab IPILIMUMAB pembrolizumab immune checkpoint inhibitors immunotherapy resistance mismatch repair deficient microsatellite instability high microsatellite stable tumor-associated macrophages myeloid-derived suppressor cells T regs T cells 
Immune checkpoint inhibitors induced colitis, stay vigilant: A case report
《World Journal of Gastrointestinal Oncology》2020年第6期699-704,共6页Suha Abu Khalaf Abdulmajeed Albarrak Mohamad Yousef Veysel Tahan 
BACKGROUND Colitis is one of the immune-related side effects of immunotherapy.Usually,such type of side effect was reported to develop within a few weeks of treatment initiation,our case started within a few days.CASE...
关键词:Immunotherapy COLITIS MELANOMA Case report IPILIMUMAB Hepatitis 
Immune Checkpoint Inhibitor Related Neuropathic Adverse Effects on Cancer Patients
《Journal of Biosciences and Medicines》2019年第6期1-12,共12页Samrat Khanal Haijun Zhang 
With the recent development and clinical application, immune checkpoint inhibitors (ICIs) intervention is being increasingly common for multiple malignancies. With these, prospect on focus creates an increasing necess...
关键词:Immune-Related ADVERSE Events IMMUNE CHECKPOINT Inhibitors Nivolumab IPILIMUMAB Lung Cancer Melanoma 
Managing cardiotoxicity associated with immune checkpoint inhibitors被引量:11
《Chronic Diseases and Translational Medicine》2019年第1期6-14,共9页Sireesha Upadhrasta Hadi Elias Keval Patel Lei Zheng 
Immuno-oncology is a fast evolving field of cancer therapy and immune checkpoint inhibitors (ICIs) are clearly a breakthrough in this field. Cardiotoxicity with conventional anti-cancer therapies has been well studied...
关键词:IMMUNE CHECKPOINT INHIBITOR CARDIOTOXICITY IPILIMUMAB Nivolumab Pembrolizumab 
Unique cytologic features of thyroiditis caused by immune checkpoint inhibitor therapy for malignant melanoma被引量:13
《Genes & Diseases》2018年第1期46-48,共3页Trevor E.Angell Le Min Tad J.Wieczorek F.Stephen Hodi 
NIH K08 HD070957(PI:Le Min,Mentor:Ursula Kaiser)。
Blockade of immune checkpoint molecules to reverse cancer-induced immune suppression can improve anti-tumor immune responses in cancer patients.Monoclonal antibodies targeting two such molecules,Programmed cell death ...
关键词:THYROIDITIS PD-1 CTLA-4 IPILIMUMAB Nivolumab CYTOLOGY 
Sustained Viral Response to Ipilimumab Treatment in a Patient with HCV Chronic Infection and Metastatic Melanoma: A Case Report
《Journal of Pharmacy and Pharmacology》2017年第5期231-236,共6页Daniel Eiger Rodrigo Coutinho Mariano Patricia Taranto Daniela Pezzutti Domingues Armentano Rene Claudio Gansl 
The treatment of metastic melanoma has rapidly evolved in the last 5 years, giving clinicians and patients the hope for long lasting responses. In the field of modern immunotherapy, we are reaching the point of an exp...
关键词:MELANOMA IMMUNOTHERAPY checkpoint inhibitors IPILIMUMAB pembrolizumab HCV. 
检索报告 对象比较 聚类工具 使用帮助 返回顶部